BioSpace News Archive

Phase 1 clinical study initiated evaluating THR-149 in diabetic macular edema (DME) Alliance extended to develop additional Bicycles for ophthalmology

MedAmerica Properties Inc. (OTC: MAMP) (“MedAmerica” or the “Company”) today announced that Vineet Bedi, CFA has been appointed to the Board of Directors, effective May 23, 2018.

Indivior PLC (LON: INDV) today announced that it has filed a regulatory submission with Australia’s Therapeutic Goods Administration (TGA) for SUBLOCADE™ (buprenorphine extended-release) injection, for subcutaneous use, for the treatment of opioid dependence within a framework of medical, social and psychological treatment. If approved, SUBLOCADE will be marketed by Indivior Pty Ltd in Australia.

Glenmark Pharmaceuticals, a global pharmaceutical company, today announced the presentation of data from two assets in its immuno-oncology portfolio at the 2018 Annual Meeting of the American Society of Clinical Oncology (ASCO).

BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today issues a statement following Congress passing the Federal “Right-to-Try” bill.

Dain Rusk will be joining Publix as Vice President of Pharmacy, effective June 1, 2018.

Firm Also Earned Band 1 Recognitions for Practices in California, Florida, Illinois, Massachusetts and Washington, D.C.

Alliance supports the Company’s strategic communications and investor relations efforts in the United States.

IMFINZI met the second primary endpoint of overall survival which was both statistically significant and clinically meaningful at a planned interim analysis

Agreement Expands Access to High-Quality, High-Value Laboratory Services for All Aetna Members